|
⚲
|
| Keyboard |
| Mina Sooch | |
|---|---|
| Firm | |
| Address | c/o Ocuphire Pharma, Inc 37000 Grand River Ave, Suite 120 Farmington Hills, MI 48335 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Ocuphire Pharma Inc | 021-381168 | Executive Officer | 21.1 M of 21.1 M |
||
| Ocuphire Pharma Inc | 021-359570 | Executive Officer | 2.1 M of 2.1 M |
||
| Biovie Inc | 021-316374 | Director | 3.2 M of 6.2 M |
||
| Ocuphire Pharma Inc | 021-313905 | Executive Officer | 1.8 M of 10.0 M |
||
| Ocuphire Pharma Inc | 021-310880 | Executive Officer | 0.0 M of 0.0 M |
||
| Gemphire Therapeutics Inc | 021-283723 | Executive Officer | 12.5 M of 12.5 M |
||
| Gemphire Therapeutics Inc | 021-245322 | Executive Officer | 10.6 M of 14.0 M |
||
| Gemphire Therapeutics Inc | 021-238001 | Executive Officer | 5.0 M of 5.0 M |
||
| Gemphire Therapeutics Inc | 021-237500 | Executive Officer | 2.7 M of 3.0 M |
||
| ProNAi Therapeutics Inc | 021-216611 | Executive Officer | 59.5 M of 59.5 M |
||
| ProNAi Therapeutics Inc | 021-209007 | Executive Officer | 11.2 M of 17.8 M |
||
| Svelte Medical Systems Inc | 021-195730 | Director | 4.3 M of 5.5 M |
||
| Svelte Medical Systems Inc | 021-180116 | Director | 5.0 M of 7.0 M |
||
| ProNAi Therapeutics Inc | 021-176136 | Executive Officer | 4.3 M of 5.0 M |
||
| Svelte Medical Systems Inc | 021-170051 | Director | 18.8 M of 35.0 M |
||
| Apjohn Ventures Annex Fund Limited Partnership | 021-150794 | Executive Officer | 1.0 M of 4.0 M |
||
| Svelte Medical Systems Inc | 021-149681 | Director | 9.7 M of 12.0 M |
||
| Cytopherx Inc | 021-143636 | Director | 11.7 M of 12.0 M |
||
| Cytopherx Inc | 021-110172 | Director | 2.0 M of 2.0 M |
||
| Svelte Medical Systems Inc | 021-102229 | Director | 4.2 M of 10.0 M |
||
| ProNAi Therapeutics Inc | 021-65428 | Director | 1.7 M of 12.0 M |
||